Liquidia Corporation (LQDA)
NASDAQ: LQDA · IEX Real-Time Price · USD
11.08
+0.09 (0.82%)
At close: Jul 19, 2024, 4:00 PM
11.02
-0.06 (-0.54%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $846.66 million as of July 22, 2024. Its market cap has increased by 71.46% in one year.
Market Cap
846.66M
Enterprise Value
776.39M
1-Year Change
71.46%
Ranking
Category
Stock Price
$11.08
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.80M to $846.66M, an increase of 404.57%. That is a compound annual growth rate of 31.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 846.30M | 8.39% |
| Dec 29, 2023 | 780.80M | 90.07% |
| Dec 30, 2022 | 410.80M | 62.31% |
| Dec 31, 2021 | 253.10M | 127.20% |
| Dec 31, 2020 | 111.40M | 39.60% |
| Dec 31, 2019 | 79.80M | -76.20% |
| Dec 31, 2018 | 335.30M | 99.82% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacira BioSciences | 901.60M |
| Humacyte | 899.08M |
| Harrow Health | 884.90M |
| AbCellera Biologics | 873.34M |
| Perspective Therapeutics | 852.32M |
| Healthcare Services Group | 846.20M |
| GeneDx Holdings | 832.38M |
| InnovAge Holding | 825.45M |